GOLGA7B Antibody - BSA Free

Western Blot: GOLGA7B Antibody [NBP1-56754]

Western Blot: GOLGA7B Antibody [NBP1-56754] - 721_B cell lysate, concentration 0.2-1 ug/ml.

Western Blot: GOLGA7B Antibody - BSA Free [NBP1-56754] -

Identification of key genes related to CCA patient survival. (A) The forest plot shows the six survival-related genes in the yellow module identified by univariate Cox regression analysis. (B) Forest plot showing that GOLGA7B and AGAP2−AS1 were independent survival-related genes determined through multivariate Cox regression analysis. (C) Kaplan–Meier curves showing that CCA patients with higher expression of GOLGA7B had a high survival probability, and those with a higher expression of AGAP2−AS1 had a lower survival probability. (D) mRNA expression of GOLGA7B and AGAP2−AS1 between tumor and normal tissues in CCA patients in the training group. (E) Analysis of Human Protein Atlas database indicated that GOLGA7B protein expression was significantly upregulated in CCA tumor tissues compared with cholangiocytes. The CCA tumor tissue came from a 67-year-old man (patient ID: 3334; staining: medium; quantity: 25%-75%; intensity: moderate). The normal tissue came from a 55-year-old man (patient ID: 2399; staining: not detected; quantity:<25%; intensity: weak). (F) qRT-PCR confirmed that GOLGA7B and AGAP2−AS1 were overexpressed in tumor samples compared to normal tissue samples. (G) Western blotting confirmed that the protein expression of GOLGA7B was significantly upregulated in tumor samples compared with normal tissue samples. * P<0.05; *** P<0.001; **** P<0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36591499), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: GOLGA7B Antibody - BSA Free [NBP1-56754] -

Identification of the biological functions of GOLGA7B and AGAP2−AS1 in CCA. (A) Knockdown of GOLGA7B and AGAP2−AS1 in RBE and HuCCT-1 cells was confirmed at the mRNA level by qRT-PCR. (B) Knockdown of GOLGA7B in RBE and HuCCT-1 cells was confirmed at the protein level by Western blotting. (C) The CCK-8 assay verified the proliferation of RBE and HuCCT-1 cells after GOLGA7B and AGAP2−AS1 depletion. (D) Transwell assays were performed to measure the migration and invasion capabilities of RBE and HuCCT-1 cells after GOLGA7B and AGAP2−AS1 depletion. ** P<0.01; *** P<0.001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36591499), licensed under a CC-BY license. Not internally tested by Novus Biologicals.